The DRDO has granted permission to manufacture and market the 2-Deoxy-D-Glucose” in the domestic market
DRDO and Dr. Reddy's anti-Covid drug 2DG will be supplied to government hospitals, central government, and state governments at a discounted price.
The company's existing range of Covid-19 therapeutics cover the full spectrum from mild to moderate and severe conditions of the disease